相关实验视频
Updated: Jun 17, 2025

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
9.5K
在解读p53在扩散大B细胞淋巴瘤中的作用方面取得进展:机制和治疗点
Wen Wen1,2, Wen-Lu Zhang1,2, Ran Tan1,2
1Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan 250021, Shandong, China.
American journal of cancer research
|August 8, 2024
概括
扩散性大B细胞淋巴瘤 (DLBCL) 涉及复杂的遗传因素,包括TP53基因. 针对TP53异常提供了改善DLBCL治疗策略和患者预后的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是最常见的成人非霍奇金淋巴瘤亚型.
- DLBCL的发病过程涉及复杂的相互作用,包括B细胞受体 (BCR) 和托尔类受体 (TLR) 信号,遗传异常和其他因素.
- 瘤蛋白p53 (TP53) 基因在DLBCL发育和患者预后方面发挥着关键作用.
研究的目的:
- 调查TP53基因异常在DLBCL发生和预后中的重要性.
- 探索针对DLBCL治疗的p53通路的治疗潜力.
- 确定改善DLBCL患者TP53变化的治疗结果的策略.
主要方法:
- 使用高通量测序对DLBCL遗传异常进行分析.
- 对p53功能,MDM2调节及其在细胞循环停止和细胞亡中的作用的现有文献的审查.
- 检查目前针对p53的治疗方法,包括功能恢复,突变p53的退化和野生类型p53的增强.
主要成果:
- 在DLBCL中经常发现TP53基因异常,并与患者预后不佳有关.
- 正常的p53功能,由MDM2调节,对于通过细胞周期控制和亡来预防瘤形成至关重要.
- 目前的疗法旨在调节p53的活性,包括恢复功能,促进突变形式的降解和稳定野生型p53.
结论:
- TP53基因异常显著影响DLBCL预后,突出了针对性治疗策略的需要.
- 向p53通路代表了新型DLBCL治疗的有希望的领域.
- 对现有的治疗方法进行进一步的研究是有必要的,以改善TP53变化DLBCL患者的治疗结果.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K

